Overcoming Misconceptions About Candidacy for Switch: Barriers to Optimizing ART in People Living With HIV and Viral Suppression
Learn to look beyond viral suppression with Brian Wood, MD, and Cristina Mussini, MD, and find out how people living with virologically suppressed HIV can still be candidates for ART switch to improve treatment satisfaction and quality of life.
Decera Clinical Education Infectious Disease Podcast · Brian R. Wood MD, Cristina Mussini MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Look beyond viral suppression to learn how people living with virologically suppressed HIV may still be candidates for antiretroviral therapy (ART) switch to improve treatment satisfaction and quality of life. Topics covered include:
- Reasons to consider regimen optimization in setting of viral suppression
- Available switch regimens, including 2-drug regimens and long-acting ART
- Approaches to assess for resistance before starting long-acting cabotegravir plus rilpivirine
- DHHS recommendations on proviral DNA genotyping
- ART optimization strategies for patients living with viral suppression and history of underlying resistance
Presenters:
Brian R. Wood, MD
Professor of Medicine
Division of Allergy and Infectious Diseases
University of Washington
Seattle, Washington
Cristina Mussini, MD
Professor of Infectious Diseases
Chief of the Division of Infectious Diseases, Policlinico, Modena
University of Modena and Reggio Emilia
Modena, Italy
Link to full program and accompanying slides:
https://bit.ly/4pAI66g
Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.